Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 8/20 | 0.40 |
| ▸ | KDM1A | O60341 | 2/20 | 0.34 |
| ▸ | GPR6 | P46095 | 2/20 | 0.34 |
| ▸ | KIT | P10721 | 3/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.33 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | JAK3 | P52333 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31342995 | 0.90 | CYP3A4 (0.39) | CYP3A4GPR6KITCHRNB4CHRNA3 | |
| SCHEMBL31343024 | 0.87 | CYP3A4 (0.41) | CYP3A4GPR6TNIK | |
| SCHEMBL31342893 | 0.86 | CYP3A4 (0.39) | CYP3A4GPR6HCRTR1HCRTR2 | |
| SCHEMBL31342844 | 0.86 | CYP3A4 (0.44) | CYP3A4 | |
| SCHEMBL31342857 | 0.85 | CYP3A4 (0.46) | CYP3A4GPR6KITTNIKCHRNB4 | |
| SCHEMBL31343043 | 0.85 | CYP3A4 (0.52) | CYP3A4 | |
| SCHEMBL31342842 | 0.82 | CYP3A4 (0.40) | CYP3A4 | |
| SCHEMBL31342929 | 0.82 | HCRTR1 (0.33) | CYP3A4HCRTR1HCRTR2CHRNB4CHRNA3 | |
| SCHEMBL31343044 | 0.81 | HCRTR1 (0.35) | HCRTR1HCRTR2CHRNB4CHRNA3 | |
| Hydrochloric Acid SCHEMBL31342858 | 0.81 | HCRTR1 (0.35) | HCRTR1HCRTR2CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025049495-A1 | TERTIARY PYRIDYL AMINE MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYLINATION | GENENTECH, INC. (US) | 2025-03-06 | — | — | WO | disclosed |